Health ❯ Women's Health ❯ Menopause

Hormone Therapy

Estrogen Therapy FDA Regulations Treatment Options Bone Health Alzheimer's Disease Risk Estrogen and Progesterone Contraception Awareness Sexual Health Cognitive Function Local Estrogen Therapy Alzheimer's Disease Tirzepatide Risks and Benefits Hormonal Impact on Bladder Health Health Risks Personal Experiences Fracture Risk Menopause Hormone Therapy Health Risks and Benefits Bone Density Alternative Treatments Dementia Risk Estrogen Patches Testosterone Breast Cancer Risk

Estrogen-Only Menopausal Therapy Linked to Fewer Alzheimer’s Markers on Autopsy

Experts call the result associative not causal; they say randomized trials must test timing, formulation and subgroup effects

Study Finds Menopausal Hormone Therapy Tied to 69% Lower Odds of Low Bone Density

FDA Says Estrogen Patches Not in Official Shortage as Pharmacies Report Scarcity

FDA Lifts Broad Black-Box Warnings From Many Menopause Hormone Therapies

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

FDA Removes Broad Boxed Warnings From Many Menopause Hormone Therapies

Timing of Menopause Hormone Therapy Linked to Divergent Alzheimer’s Risks

Estradiol Therapy Route Tied to Different Memory Skills After Menopause, Study Finds

FDA Begins Expert Review of Menopause Hormone Therapy Warnings